Another important ABC transporter, BCRP, encoded by the ABCG2 on chromosome 4, has been linked to drug resistance in the treatment of AML with chemotherapeutic agents such as doxorubicin, daunorubicin, vincristine, mitoxantrone, and methotrexate (80). The gene discussed is ABCG2; the disease is acute myeloid leukemia.